US Markets

The Fed's G.17 release landed at 9:15 am ET Friday and the headline looked boring. It wasn't. Industrial production printed flat at 0.0% in August against a +0.3% consensus — and that flat number is hiding a factory sector that went backwards. The numbers Total output was 0.0% month-on-month , missing the +0.3% forecast and slowing from an unrevised +0.2% in July. Year-on-year it's up 1.4% . Manufacturing is the real story. Factory output fell 0.3% against a Reuters poll looking for +0.3% — a 0.6-point miss, and the first decline after seven straight months of gains. It's up just 0.9% from a year ago. The breakdown, as reported by Reuters: Mo…

What happened Strategy (NASDAQ: MSTR) — the company that used to be MicroStrategy — ripped higher on a day the S&P 500 went nowhere. Investing.com has it closing at $153.92, up 16.39% — a $21.67 day on 50.29m shares, against a 52-week range of $81.81 to $365.21. Yahoo Finance clocked it at $148.55, about +12%, at 11:57 am ET, so the last two hours did real work. Nothing changed inside the company. Bitcoin climbed back above $80,000 at the US open, up about 5.5% in 24 hours and topping $81,000 intraday after weekly lows near $75,000 (CoinDesk). Why it moved 1. Bitcoin bounced, and Strategy's cost base is right there. It holds 845,050 BTC at an…

What happened Nucor , the largest steelmaker in the United States, is at $249.87, down 5.76% (−$15.27) as reported by StockAnalysis at 10:50 am ET. The trigger landed Thursday after the close: Nucor guided third-quarter earnings to $5.55–$5.65 per diluted share . Analysts sat around $6.17–$6.20 . That gap, roughly 55 to 65 cents a share, is the whole move. Why it moved, when the number itself looks fine Here is what the headline buries. The guide is higher than the quarter before it — Q2 was $5.04 reported, $4.84 adjusted — and more than double the $2.63 of the same quarter in 2025. It is also cleaner, because Q2 carried $130 million of one-o…

Xenon Pharmaceuticals fell about 25% to $42.84 in Friday premarket , against Thursday's $57.35 close — its worst single day since March 2017, per CoinCentral. It went in with a $5.6bn market cap after a 52% gain over the prior year. The trigger landed after Thursday's bell. Xenon voluntarily paused new patient enrolment in its psychiatry programme for azetukalner after reviewing neuropsychiatric adverse events — reported as confusion, somnolence, ataxia and rare cases of psychosis. That covers three Phase 3 X-NOVA studies in major depression (~450 patients each) and two Phase 3 X-CEED studies in bipolar depression (~400 each) . Patients alrea…

Two weeks ago Ultragenyx lost almost half its value in a single session. On Thursday it got the approval that survived the wreckage. Ultragenyx (RARE) closed at $14.50, up 12.58% (+$1.62) on Sep 17, per StockAnalysis; Reuters had it &#34;over 10%&#34; in afternoon trade. Market cap: about $1.43bn. The catalyst, with a number on it The FDA approved FAYUVI (rebisufligene etisparvovec-hopf, formerly UX111) — the first-ever approved treatment for Sanfilippo syndrome type A. In the pivotal dataset, 17 treated patients scored 23.5 points higher on cognition than a 27-patient untreated natural-history cohort (p<0.0001), with follow-up running close…

What happened INNIO N.V. (NASDAQ: INIO) closed up about 12% at $20.96 , from Wednesday's $18.71, touching $21.61 intraday on roughly 10.0 million shares . The trigger: a firm order for 450 megawatts of Jenbacher J624 containerised gas engines, booked in Q3 2026, from an unnamed US energy company. Delivery is due by 2028 , and INNIO says it's the customer's first order of that size. Why it moved — two things, not one Don't blur these. The order is the big one. But a day earlier, on 16 September , Moody's upgraded INNIO's corporate family rating from B1 to Ba3 and moved the outlook to positive, citing tighter financial policy after the IPO and…

Vicor is up ~18.3% to $217.63 , from a $183.91 previous close, as of 2:18 pm ET — roughly $1.5bn of market value added in a session. Benzinga clocked it at +15.1% ($211.66) earlier in the day. It's one of the biggest movers on the tape today. The trigger was a press release dated Sept 16: Vicor licensed its Vertical Power Delivery (VPD) technology to an unnamed &#34;leading AI OEM.&#34; No customer named. No dollar figure disclosed. And the stock still ripped. Read the terms, not the headline The licence is non-exclusive — and here's the part that matters: the licensee can buy VPD modules from suppliers who don't hold a Vicor licence and rema…

What happened Moderna is up about 9.7% at $159.77 as of 11:50am ET, having traded between $149.50 and $161.96 against Wednesday's close of $145.62 . Investing.com reported it up 9.39% at $159.43 in morning trade. Now the strange bit: there's no Moderna news today. No data, no filing, no earnings, no deal. Investing.com puts it down to momentum buying and short-squeeze dynamics. The Nasdaq rose 1.51% in the same session, so roughly eight points of this belong to Moderna alone. What the market's still chewing on happened four weeks ago. Why it moved On 19 August 2026 , Merck and Moderna said their Phase 3 trial, INTerpath-001, met its endpoints…

Fluence Energy (FLNC) is down about 17% at $7.52 , a few cents off its $7.01 52-week low, after cutting full-year guidance for the second time in six weeks. It fell 22% after hours on Wednesday. The cut, in actual numbers Fluence now expects FY2026 revenue of about $2.4bn, down from a prior midpoint of $3.0bn — $600m gone. Adjusted EBITDA goes from a roughly $10m loss to a $200m loss — a $190m swing in one press release. It isn't demand. It's one building. CEO Julian Nebreda said demand stayed strong at home and abroad and the international supply chain kept working. It pinned the revision on delays ramping up its contract manufacturing facil…

Generac makes the generator that kicks in when the power cuts out, and its sales had gone nowhere for two years. Then Amazon signed a supply deal with it on Wednesday evening. By Thursday premarket the stock was quoted near $236 against Wednesday's close of $175.11 — up roughly 35% , as reported by Benzinga and MarketWatch. What happened Generac's 8-K, filed with the SEC on 16 September, is unusually specific. It signed a long-term supply agreement with Amazon for backup generators for Amazon's data centres, with initial deliveries expected to total $2.4 billion across 2027 and 2028 . The headline &#34;$8 billion&#34; is a different thing: it…

Intel closed Wednesday at $101.05, up 4.03% , on a Reuters report that SK hynix is in talks to make memory chips at an Intel plant in the US. Read the report closely and there is no deal in it — and both companies say so out loud. What was actually reported Intel (NASDAQ: INTC) and SK hynix are exploring two structures, per Reuters: SK hynix leasing part of Intel's planned Ohio complex, or a joint venture that could pull in cloud providers as buyers. The talks are exploratory — no decision on the structure, and no decision on which memory (DRAM, HBM or NAND) would even be made. SK hynix said it is &#34;reviewing various options, including add…

What happened LuxExperience (NYSE: LUXE) — owner of Mytheresa, NET-A-PORTER, MR PORTER and YOOX — reported Q4 and full-year FY26 before the US open. The stock ran from a $7.15 prior close to a $9.16 high, and sat near $8.77, up ~22.7% , late in Wednesday's session on about 2.07m shares (Yahoo Finance, 15:41 ET). Q4 net sales were €663.8m , up 7.6% in constant currency, against the roughly €643.9m the street modelled. Adjusted EPS was −€0.18 versus −€0.07 expected (Investing.com). Sales beat, profit missed, stock up a fifth. That gap is the story. Why it moved: the profit collapse is an accounting ghost The scary line is a net loss of €26.3m a…

One sentence from a US cabinet official knocked 9% off Diamondback before lunchtime in New York. Nothing happened at the company. Here's the chain. What happened Diamondback Energy (NASDAQ: FANG) was at $192.01 , down $19.52 or 9.23% from Tuesday's close of $211.53, as reported by Nasdaq at 11:48 AM ET. Volume was about 6.6 million shares against an average day of 1.85 million — roughly 3.6x normal . Market cap is around $54 billion. No filing, no guidance cut, no downgrade. The move came from the barrel. Trading Economics has WTI at $101.15, down 4.42% , and Brent at $104.65, down 3.77% . Why it moved On 11 September, Saudi Arabia's East–Wes…

J.B. Hunt is the ugliest chart on the board today. The intermodal and trucking giant trades at $240.85, down about 11.8% , after telling investors at the Morgan Stanley Laguna Conference that third-quarter earnings will land 5–10% below the second quarter. The size of the cut isn't the shock. The direction is. Consensus had Q3 EPS up roughly 12% sequentially from Q2's adjusted $1.91 ; BMO was at +11%. The company's guide implies about $1.72–$1.81 . That's a ~20-point swing the wrong way, delivered mid-quarter with no earnings release to cushion it — hence a one-session repricing. And it follows a Q2 that grew: revenue $3.50bn, up 19% YoY , op…

The numbers The US Census Bureau's advance estimate landed at 8:30 am ET. Retail and food services sales came in at $773.9 billion for August, up 1.2% on July and 6.0% on August 2025. Consensus was +0.8% . July, which first printed at −0.6%, was revised up to −0.5% . Take cars out and it improves rather than fades: sales excluding motor vehicles and parts rose 1.4% ; excluding autos and petrol both, 1.2% . The control group — the slice the Fed and the GDP statisticians actually use — rose 1.4% against a forecast near 0.4% , after a 0.4% fall in July. Month on month, by category (Census Table 2): Nonstore (online) retailers +2.6% — the biggest…

What happened Shares of Veea Inc. (NASDAQ: VEEA) rocketed about 82% in Wednesday's trading on heavy volume of roughly 38 million shares — and that's on top of a roughly 149% surge the session before (from a $2.29 close to around $5.71). Zoom out and it gets wilder: this was a sub- $0.20 stock in late August. In about three weeks it has gone up many times over. Why it moved The trigger is a deal. After Monday's close, Veea and Amsterdam-based NovaGen Group B.V. said they'd signed a term sheet to combine and launch &#34;NovaGen Health Networks&#34; — a platform bolting Veea's edge computing and cybersecurity onto NovaGen's cellular-reprogrammin…

Rumble (NASDAQ: RUM) rocketed as much as ~27% to about $1.99 — Yahoo Finance has the 27% and the price; 24/7 Wall St. clocked a first ~10% pop on the initial report, with the fuller run coming once the mystery customer was named. Here's the twist: the customer is Anthropic , the AI lab behind Claude. The Information reported that Rumble — yes, the video platform — landed a six-year, $13.7 billion compute contract . That's roughly $2.28 billion of contracted revenue a year for a company whose entire market value was a fraction of the deal's size. Rumble supplies the horsepower through Northern Data, which it's absorbing (~22,000 Nvidia H100/H2…

What happened Tempus AI ( TEM ) is up about 10.1% today, at $68.48 against yesterday's $62.21 close , as reported by StockAnalysis — one of the biggest large-cap gains on the US movers board. Market cap is about $12.36bn . Here's the odd part: there was no filing and no results today. No 8-K, no deal, no earnings. What there was, per Tempus's own 4 September release, is CEO Eric Lefkofsky doing a fireside chat at Morgan Stanley's 24th Annual Global Healthcare Conference — scheduled for today, 15 September. Why it moved The takeaway circulating from that chat is narrow and specific: the diagnostics and data businesses are compounding, and FDA…

Dave & Buster's ( PLAY ) is down about 16% today, to roughly $7.31 , one of the deepest drops on the US movers board, after Monday evening's Q2 report. It was already down 48% on the year going in. The headline miss is small. Revenue was $544.1m, down 2.4% from $557.4m, against a ~$556.8m street number. Comparable store sales fell 2.9% . A 2.4% revenue slip does not, by itself, take a sixth off a share price. What actually broke: the drop-through Adjusted EBITDA came in at $98.9m versus $129.8m a year ago. Revenue fell about $13m; EBITDA fell about $31m. That's roughly $2.30 of profit gone for every $1 of lost sales , and margin down from abo…

What happened Axon Enterprise — the TASER and police body-camera company — is down about 9.3% today, near $444.77 against yesterday's $490.18 close, as reported by Yahoo Finance. It's among the S&P 500's worst performers on the day. Nothing broke at the company. Before the open, Axon launched a $1.0 billion offering of 0% convertible senior notes due September 2031 , plus a $150 million over-allotment option, per the 8-K and prospectus supplement it filed with the SEC. So it's borrowing a billion dollars at zero interest — and the stock fell nearly a tenth. Why it moved A convertible bond is a loan that can turn into shares. The lender gives…